630
Participants
Start Date
December 15, 2025
Primary Completion Date
December 14, 2029
Study Completion Date
December 14, 2029
Cilostazol (Pletal®) 100 mg Tablets
100 mg orally or via feeding tube twice daily for 14 days, starting within 96 hours after aneurysmal subarachnoid hemorrhage onset. Tablets may be crushed for enteral administration.
Placebo
Oral or enteral placebo, visually identical to cilostazol, twice daily for 14 days, starting within 96 hours after hemorrhage onset.
Nimodipine group
Administered orally, enterally, or intravenously for 21 days as part of standard of care. Dose, route, and duration determined by treating physician according to clinical condition and guidelines.
Centre Hospitalier St Anne
OTHER